Rain Therapeutics Inc. (RAIN) CEO Avanish Vellanki on Q1 2022 Results - Earnings Call Transcript
Rain Therapeutics Inc. (NASDAQ:NASDAQ:RAIN) Q1 2022 Results Conference Call May 04, 2022 05:00 PM ET Company Participants Bob Yedid - LifeSci Advisors Avanish Vellanki - CEO Robert Doebele...
Source: seekingalpha.com